Surveillance for the Use of Anti-MRSA Drugs in Pediatric Hospitals-Reference-Cited by-同舟云学术

Surveillance for the Use of Anti-MRSA Drugs in Pediatric Hospitals

Published:2024-05-20 Issue:3 Volume:98 Page:293-300
ISSN:0387-5911
Container-title:Kansenshogaku Zasshi
language:en
Short-container-title:kansenshogakuzasshi

Author:

NAGASAWA Koo¹²,WATANABE Taijiro²,HARAKI Yu²,KUSANO Taizo²,YAMAMOTO Shota²,ISHIWADA Ryo³,SATO Mari⁴,FUKASAWA Chie²⁵,HOSHINO Tadashi²

Affiliation:

1. Department of pediatrics, Graduate School of Medicine, Chiba University

2. Division of Infectious Diseases, Chiba Children's Hospital

3. Division of pharmacy, Chiba Children's Hospital

4. Division of clinical examination, Chiba Children's Hospital

5. Iwata Children's Clinic

Publisher

The Japanese Association for Infectious Diseases

Link

https://www.jstage.jst.go.jp/article/kansenshogakuzasshi/98/3/98_e23014/_pdf

Reference18 articles.

1. 1) Kaplan SL, Hulten KG, Mason EO: Staphylococcus aureus Infections. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases eighth edition. Elsevier, Philadelphia, 2019; p. 794-807.

2. 2) JANIS集計データ (全国集計版). AMED薬剤耐性菌のサーベイランス強化および薬剤耐性菌の総合的な対策に資する研究 [Internet]. [cited 2023 Feb 8]; Available from: https://www.niid.go.jp/niid/ja/from-lab/2415-amrc/9201-janis-glass-excel-jp.html.

3. 3) 小児領域感染症, MRSA感染症の治療ガイドライン作成委員会編: MRSA感染症の治療ガイドライン (公益社団法人日本化学療法学会・一般社団法人日本感染症学会). 東京, 2019; p. 107-14.

4. 4) Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al.: Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52: e18-55.

5. 5) Kanda Y: Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013; 48: 452-8.